Delta opiate receptors account for the castration-induced unmasking of gonadotropin-releasing hormone binding sites in the rat pituitary

Neuroendocrinology

Volumn 68, Issue 6, 1998, Pages 386-394

  Leblanc, Pierre ^a   L'Héritier, Andrée ^a   Kordon, Claude ^a  

^a INSERM   (France)

Author keywords

Castration; Gonadal steroids; Gonadotropin releasing hormone; Growth factors; Neuropeptide Y; Opiate peptide receptors; Opiate peptides; Protein kinases

Indexed keywords

BETA ENDORPHIN; DELTA OPIATE RECEPTOR; DYNORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GONADORELIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HERBIMYCIN; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MORPHINE; NALOXONE; NALTRINDOLE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROTEIN INHIBITOR; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CASTRATION; CONTROLLED STUDY; ENZYME INHIBITION; HORMONE BINDING; HYPOPHYSIS; HYPOPHYSIS CELL; MALE; MASKING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; SECOND MESSENGER;

ANIMALS; ANTIMETABOLITES; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; LIGANDS; MALE; NEUROPEPTIDE Y; OPIOID PEPTIDES; ORCHIECTOMY; PITUITARY GLAND; RATS; RECEPTORS, LHRH; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION;

EID: 0032406436     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054388     Document Type: Article

References (46)

1. Huckle WR, McArdle CA, Conn PM: Differential sensitivity of agonist- and antagonist-occupied gonadotropin-releasing hormone receptors to protein kinase C activators. J Biol Chem 1988;263:3296-3302.
2. Leblanc P, Haour F, L'Héritier A, Mounier F, Kordon C: Temperature and protein kinase C modulation of gonadotropin-releasing hormone receptors in pituitary cells from intact or castrated male rats. J Neuroendocrinol 1990;2: 509-515.
3. 2+ calmodulin-dependent kinase rather than protein kinase C is involved in up-regulation of the LHRH receptor. Biochem Biophys Res Commun 1992;183:666-671.
4. Leblanc P, L'Héritier A, Kordon K: Cryptic gonadotropin-releasing hormone receptors of rat pituitary cells in culture are unmasked by epidermal growth factor. Endocrinology 1997; 138:574-579.
5. Leblanc P, L'Héritier A, Rasolonjanahary R, Kordon C: Neuropeptide Y enhances LHRH binding to rat gonadotrophs in primary culture. Neuropeptides 1994;26:87-92.
6. Nett TM, Akbar AM, Niswender GD, Hedlund MT, White WF: A radioimmunoassay for gonadotropin-releasing hormone in serum. J Clin Endocrinol Metab 1973;36:880-885.
7. June CH, Flechter MC, Ledbetter JA, Schieven GL, Siegel JN, Phillips AF, Samelson LE: Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc Natl Acad Sci USA 1990;87:7722-7726.
8. Strulovici B, Tahilramani R, Nestor JJ Jr: Phosphorylation substrates for protein kinase C in intact pituitary cells: Characterization of a receptor-mediated event using novel gonadotropin-releasing hormone analogues. Biochemistry 1987;26:6005-6011.
9. Parker RB, Waud DR: Pharmacological estimation of drug receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther 1971;177:1-12.
10. Gilman AG: G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 1987;56:615-649.
11. Birnbaumer L, Abramowitz J, Brown AM: Receptor-effector coupling by G proteins. Biochim Biophys Acta 1990;1031:163-224.
12. Levitzki A, Gazit A: Tyrosine kinase inhibition: An approach to drug development. Science 1995;267:1782-1788.
13. Smallridge RC, Kiang JG, Gist ID, Fein GH, Galloway RJ: U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells. Endocrinology 1992; 131:1883-1888.
14. Simon EJ: Opioid receptors and endogenous opioid peptides. Med Res Rev 1991;11:357-374.
15. Lutz RA, Pfister HP: Opioid receptors and their pharmacological profiles. J Recept Res 1992;12:267-286.
16. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T: Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol Pharmacol 1994;45:330-334.
17. Portoghese PS, Sultana M, Takemori AE: Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur J Pharmacol 1988;146:185-186.
18. Ward SJ, Portoghese PS, Takemori AE: Pharmacological characterisation in vivo of the novel opiate, β-funaltrexamine. J Pharmacol Exp Ther 1982;220:494-498.
19. Recht LD, Pasternak GW: Effects of β-funaltrexamine on radiolabeled opioid binding. Eur J Pharmacol 1987;140:209-214.
20. Takemori AE, Ho Y, Naeseth JS, Portoghese PS: Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 1988;246:255-258.
21. Gacel G, Fournie-Zaluski MC, Roques BP: D-tyr-Ser-Gly-Phe-Leu-Thr, a highly preferential ligand for delta-opiate receptors. FEBS Lett 1980;118:245-247.
22. Kosterlitz HW, Paterson SJ, Robson LE: Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain. Br J Pharmacol 1981;73:939-949.
23. Ramabadran K, Bansinath M, Tundorf H, Puig MM: Kappa-opiate agonist-induced inhibition of gastrointestinal transit in different strains of mice. Pharmacology 1991;42:97-102.
24. Tramu G, Leonardelli J: Immunohistochemical localization of enkephalins in median eminence and adenohypophysis. Brain Res 1979; 168:457-471.
25. Weber E, Voigt KH, Martin R: Pituitary somatotrophs contain methenkephaline-like immunoreactivity. Proc Natl Acad Sci USA 1978;75: 6134-6138.
26. Roth KA, Lorenz RG, McKeel DW, Leykam J, Barchas JD, Tyler AN: Methionine-enkephalin and thyrotropin-stimulating hormone are intimately related in the human anterior pituitary. J Clin Endocrinol Metab 1988;66:804-810.
27. Bloom F, Battenberg E, Rossier J, Ling N, Leppaluoto J, Vargo TM, Guillemain R: Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis. Life Sci 1977;20:43-48.
28. Khatchaturian H, Sherman TG, Lloyd RV, Civelli O, Douglas J, Herbert E, Akil H, Watson SJ: Prodynorphin is endogenous in the anterior pituitary and is colocalised with LH and FSH in the gonadotrophs. Endocrinology 1986;119:1409-1411.
29. Rhee SG, Suh PG, Ryu SH, Lee SY: Studies of inositol phospholipid specific phospholipase C. Science 1989;244:546-550.
30. Bell RM, Burns DJ: Lipid activation of protein kinase C. J Biol Chem 1991;266:4661-4664.
31. Wahl MI, Jones GA, Nishibe S, Rhee SG, Carpenter G: Growth factor stimulation of phospholipase C-gamma I activity. Comparative properties of control and activated enzymes. J Biol Chem 1992;267:10447-10456.
32. Meisenhelder J, Suh PG, Hunter T: Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein kinases in vivo and in vitro. Cell 1989;57:1109-1122.
33. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-212.
34. Horsthemke B, Leblanc P, Kordon C, Wattiaux-de-Coninck S, Wattiaux R, Bauer K: Subcellular distribution of particle-bond neutral peptidases capable of hydrolysing gonadoliberin, thyroliberin, enkephalin and substance P. Eur J Biochem 1984;139:315-320.
35. Schwartz JC, Malfroy B, De La Baume S: Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ('enkephalinase') as neuropeptidase. Life Sci 1981;29:1715-1740.
36. Hsia JA, Moss J, Hewlett EL, Vaughan M: ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. J Biol Chem 1984;259:1086-1090.
37. Attali B, Saya D, Vogel Z: κ-Opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord. J Neurochem 1989;52:360-369.
38. Puttfarcken PS, Werling LL, Cox BM: Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: A useful model for the study of tolerance at mu opioid receptors. Mol Pharmacol 1988;33:520-527.
39. 2 by G proteins βγ subunits. Nature 1992;360:683-686.
40. 2 isoform of phospholipase C. Nature 1992;360:686-689.
41. 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 1993;268:4625-4636.
42. Leff P: The two-state model of receptor activation. Trends Pharmacol Sci 1995;16:89-97.
43. Costa T, Herz A: Antagonists with negative intrinsic activity as δ opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 1989;86:7321-7325.
44. Schütz W, Feissmuth M: Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol Sci 1992;13:376-380.
45. Lefkowitz RJ, Cotecchia S, Samama P, Costa T: Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 1993;14:303-307.
46. Ibrahim SN, Moussa SM, Childs GV: Morphometric studies of rat anterior pituitary cells after gonadectomy: Correlation of changes in gonadotropes with the serum levels of gonadotropins. Endocrinology 1986;119:629-637.